117 related articles for article (PubMed ID: 8906594)
1. Anti-herpes simplex virus activity of n-docosanol correlates with intracellular metabolic conversion of the drug.
Pope LE; Marcelletti JF; Katz LR; Katz DH
J Lipid Res; 1996 Oct; 37(10):2167-78. PubMed ID: 8906594
[TBL] [Abstract][Full Text] [Related]
2. Antiviral activity of 1-docosanol, an inhibitor of lipid-enveloped viruses including herpes simplex.
Katz DH; Marcelletti JF; Khalil MH; Pope LE; Katz LR
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10825-9. PubMed ID: 1660151
[TBL] [Abstract][Full Text] [Related]
3. The anti-herpes simplex virus activity of n-docosanol includes inhibition of the viral entry process.
Pope LE; Marcelletti JF; Katz LR; Lin JY; Katz DH; Parish ML; Spear PG
Antiviral Res; 1998 Dec; 40(1-2):85-94. PubMed ID: 9864049
[TBL] [Abstract][Full Text] [Related]
4. Synergistic inhibition of herpesvirus replication by docosanol and antiviral nucleoside analogs.
Marcelletti JF
Antiviral Res; 2002 Nov; 56(2):153-66. PubMed ID: 12367721
[TBL] [Abstract][Full Text] [Related]
5. n-docosanol: broad spectrum anti-viral activity against lipid-enveloped viruses.
Katz DH; Marcelletti JF; Pope LE; Khalil MH; Katz LR; McFadden R
Ann N Y Acad Sci; 1994 Jun; 724():472-88. PubMed ID: 8030975
[No Abstract] [Full Text] [Related]
6. Intracellular imaging of docosanol in living cells by coherent anti-Stokes Raman scattering microscopy.
You S; Liu Y; Arp Z; Zhao Y; Chaney EJ; Marjanovic M; Boppart SA
J Biomed Opt; 2017 Jul; 22(7):70502. PubMed ID: 28742922
[TBL] [Abstract][Full Text] [Related]
7. Comparison of new topical treatments for herpes labialis: efficacy of penciclovir cream, acyclovir cream, and n-docosanol cream against experimental cutaneous herpes simplex virus type 1 infection.
McKeough MB; Spruance SL
Arch Dermatol; 2001 Sep; 137(9):1153-8. PubMed ID: 11559210
[TBL] [Abstract][Full Text] [Related]
8. Metabolism and mode of action of (R)-9-(3,4-dihydroxybutyl)guanine in herpes simplex virus-infected vero cells.
Stenberg K; Larsson A; Datema R
J Biol Chem; 1986 Feb; 261(5):2134-9. PubMed ID: 2418021
[TBL] [Abstract][Full Text] [Related]
9. Topical n-docosanol for management of recurrent herpes labialis.
Treister NS; Woo SB
Expert Opin Pharmacother; 2010 Apr; 11(5):853-60. PubMed ID: 20210688
[TBL] [Abstract][Full Text] [Related]
10. Docosanol: a topical antiviral for herpes labialis.
Leung DT; Sacks SL
Expert Opin Pharmacother; 2004 Dec; 5(12):2567-71. PubMed ID: 15571473
[TBL] [Abstract][Full Text] [Related]
11. Antiviral and virucidal activities against herpes simplex viruses of umesu phenolics extracted from Japanese apricot.
Nishide M; Ikeda K; Mimura H; Yoshida M; Mitani T; Hajime Koyama A
Microbiol Immunol; 2019 Sep; 63(9):359-366. PubMed ID: 31301156
[TBL] [Abstract][Full Text] [Related]
12. Botryosphaeran and sulfonated derivatives as novel antiviral agents for herpes simplex and dengue fever.
Sacchelli BAL; Faccin-Galhardi LC; Ito VY; Lopes JL; Dekker RFH; Barbosa-Dekker AM; Orsato A
Int J Biol Macromol; 2019 Oct; 138():334-339. PubMed ID: 31302130
[TBL] [Abstract][Full Text] [Related]
13. Extreme sensitivity of enveloped viruses, including herpes simplex, to long-chain unsaturated monoglycerides and alcohols.
Sands J; Auperin D; Snipes W
Antimicrob Agents Chemother; 1979 Jan; 15(1):67-73. PubMed ID: 218499
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial.
Sacks SL; Thisted RA; Jones TM; Barbarash RA; Mikolich DJ; Ruoff GE; Jorizzo JL; Gunnill LB; Katz DH; Khalil MH; Morrow PR; Yakatan GJ; Pope LE; Berg JE;
J Am Acad Dermatol; 2001 Aug; 45(2):222-30. PubMed ID: 11464183
[TBL] [Abstract][Full Text] [Related]
15. Incorporation and metabolism of 2'-fluoro-5-substituted arabinosyl pyrimidines and their selective inhibition of viral DNA synthesis in herpes simplex virus type 1 (HSV-1)-infected and mock-infected Vero cells.
Kong XB; Scheck AC; Price RW; Vidal PM; Fanucchi MP; Watanabe KA; Fox JJ; Chou TC
Antiviral Res; 1988 Dec; 10(4-5):153-66. PubMed ID: 2852483
[TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus-specified DNA polymerase is the target for the antiviral action of 9-(2-phosphonylmethoxyethyl)adenine.
Foster SA; Cerny J; Cheng YC
J Biol Chem; 1991 Jan; 266(1):238-44. PubMed ID: 1845964
[TBL] [Abstract][Full Text] [Related]
17. n-Docosanol 10% cream in the treatment of recurrent herpes labialis: a randomised, double-blind, placebo-controlled study.
Habbema L; De Boulle K; Roders GA; Katz DH
Acta Derm Venereol; 1996 Nov; 76(6):479-81. PubMed ID: 8982417
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of the carbocyclic analogue of (E)-5-(2-iodovinyl)-2'-deoxyuridine in herpes simplex virus-infected cells. Incorporation of C-IVDU into DNA.
De Clercq E; Bernaerts R; Balzarini J; Herdewijn P; Verbruggen A
J Biol Chem; 1985 Sep; 260(19):10621-8. PubMed ID: 2993282
[TBL] [Abstract][Full Text] [Related]
19. Virucidal activities of medium- and long-chain fatty alcohols, fatty acids and monoglycerides against herpes simplex virus types 1 and 2: comparison at different pH levels.
Hilmarsson H; Kristmundsdóttir T; Thormar H
APMIS; 2005 Jan; 113(1):58-65. PubMed ID: 15676016
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of lipid-containing viruses by long-chain alcohols.
Snipes W; Person S; Keller G; Taylor W; Keith A
Antimicrob Agents Chemother; 1977 Jan; 11(1):98-104. PubMed ID: 189684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
